Cassava Sciences: Fine Trading Stock, Terrible Investment
| Stock Market News, Stock Advice & Trading Tips • October 11, 2021, 2:11 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SAVA stock has fallen sharply in recent weeks. However, it's still a rather expensive bet on a controversial drug heading into Phase 3…
| Stock Market News, Stock Advice & Trading Tips • October 11, 2021, 2:33 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Protagonist Therapeutics (PTGX) stock is rocketing higher on Monday thanks to an update from the FDA concerning rusfertide clinical…
Comments
Post a Comment